Substituted Morpholines Modulating Calcium Sensing Receptor

The patent applies local quality by designing compounds with specific substituent patterns at defined positions on the morpholine ring and aromatic groups. The structure requires substituents at specific locations (e.g., R1, R2, R3, R4 positions) with particular properties (electron-withdrawing or electron-donating groups, cyclic or acyclic structures), creating localized functional regions that enhance binding specificity to the CaSR receptor while maintaining overall molecular efficacy.

The patent employs parameter changes by systematically varying structural parameters of the morpholine core compound, including substituent types (halogen, alkyl, aryl, heteroaryl groups), substituent positions, and chain lengths (m, n, p values). These parameter modifications optimize the balance between receptor binding specificity and biological efficacy, transforming a general treatment approach into a targeted therapy with improved therapeutic index.

The patent applies segmentation by dividing the molecule into distinct functional segments: a core morpholine heterocyclic unit, aromatic substituent groups (phenyl, naphthyl), and linker chains. Each segment contributes specifically to receptor interaction - the morpholine core provides allosteric modulation, while aromatic groups enhance binding affinity. This modular segmentation allows optimization of sensitivity without creating a monolithic complex structure, facilitating both design and synthesis.

The patent implements universality by designing the morpholine core structure to perform multiple functions simultaneously: it serves as the allosteric binding site, provides structural rigidity, and offers multiple positions for substituent attachment that fine-tune receptor interaction. The aromatic groups likewise provide both steric positioning and electronic modulation. This multi-functionality reduces the need for additional separate molecular components, managing complexity while enhancing sensitivity.